Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Current Assets (2016 - 2025)

Historic Current Assets for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to $254.1 million.

  • Mimedx's Current Assets rose 4761.04% to $254.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $254.1 million, marking a year-over-year increase of 4761.04%. This contributed to the annual value of $191.9 million for FY2024, which is 1681.77% up from last year.
  • Latest data reveals that Mimedx reported Current Assets of $254.1 million as of Q3 2025, which was up 4761.04% from $220.9 million recorded in Q2 2025.
  • In the past 5 years, Mimedx's Current Assets ranged from a high of $254.1 million in Q3 2025 and a low of $131.0 million during Q2 2022
  • Its 5-year average for Current Assets is $160.5 million, with a median of $148.5 million in 2021.
  • As far as peak fluctuations go, Mimedx's Current Assets plummeted by 1724.58% in 2021, and later surged by 4761.04% in 2025.
  • Over the past 5 years, Mimedx's Current Assets (Quarter) stood at $148.5 million in 2021, then decreased by 9.64% to $134.2 million in 2022, then grew by 22.4% to $164.3 million in 2023, then grew by 16.82% to $191.9 million in 2024, then skyrocketed by 32.42% to $254.1 million in 2025.
  • Its Current Assets stands at $254.1 million for Q3 2025, versus $220.9 million for Q2 2025 and $200.1 million for Q1 2025.